Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001085838 | SCV000283901 | benign | Gastrointestinal stromal tumor | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000233334 | SCV001154194 | likely benign | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001010783 | SCV001171025 | likely benign | Hereditary cancer-predisposing syndrome | 2018-12-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003977645 | SCV004795098 | benign | KIT-related disorder | 2023-12-05 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |